A rare cause of esophagitis with crystal deposition.
作者信息
Gaduputi Vinaya, Tariq Hassan, Ihimoyan Ariyo
出版信息
Can J Gastroenterol Hepatol. 2015 Apr;29(3):123-4. doi: 10.1155/2015/151359.
Abstract
摘要
相似文献
1
A rare cause of esophagitis with crystal deposition.
Can J Gastroenterol Hepatol. 2015 Apr;29(3):123-4. doi: 10.1155/2015/151359.
2
Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma.
Eur J Surg Oncol. 2011 Jun;37(6):466-72. doi: 10.1016/j.ejso.2011.01.027. Epub 2011 Mar 16.
3
A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
Am J Clin Oncol. 2010 Jun;33(3):246-50. doi: 10.1097/COC.0b013e3181a650d4.
4
Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up.
Br J Cancer. 2001 Apr 6;84(7):878-80. doi: 10.1054/bjoc.2000.1472.
5
Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Hepatogastroenterology. 2014 Jun;61(132):972-7.
6
[Value of postoperative radiochemotherapy with 5-fluorouracil plus leucovorin in stage IB-IV M0 stomach carcinoma].
Strahlenther Onkol. 2002 Mar;178(3):164-6.
7
No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.
Am J Clin Oncol. 2011 Jun;34(3):309-13. doi: 10.1097/COC.0b013e3181dea94e.
8
Adjuvant chemotherapy for gastric cancer or not: a dilemma?
J Natl Cancer Inst. 2008 Mar 19;100(6):376-7. doi: 10.1093/jnci/djn055. Epub 2008 Mar 11.
9
[Effect of preoperative FPL (5-fluorouracil, cisplatin, leucovorin) therapy on patients with primary unresectable advanced gastric cancer].
Gan To Kagaku Ryoho. 1993 Feb;20(2):303-6.
10
[Cancer of the gastric antrum].
J Chir (Paris). 2003 Jun;140(3):176-8.
本文引用的文献
1
Emerging evidence on the pathobiology of mucositis.
Support Care Cancer. 2013 Nov;21(11):3233-41. doi: 10.1007/s00520-013-1900-x. Epub 2013 Jul 11.
2
5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging.
PLoS One. 2012;7(3):e31808. doi: 10.1371/journal.pone.0031808. Epub 2012 Mar 7.
3
Esophagitis dissecans superficialis and autoimmune bullous dermatoses: A review.
World J Gastrointest Endosc. 2010 Jul 16;2(7):252-6. doi: 10.4253/wjge.v2.i7.252.
4
Esophagitis dissecans superficialis ("sloughing esophagitis"): a clinicopathologic study of 12 cases.
Am J Surg Pathol. 2009 Dec;33(12):1789-94. doi: 10.1097/PAS.0b013e3181b7ce21.
5
Pathobiology of oral mucositis: novel insights and opportunities.
J Support Oncol. 2007 Oct;5(9 Suppl 4):3-11.
6
Esophagitis dissecans superficialis associated with bisphosphonates.
Endoscopy. 2007 Feb;39 Suppl 1:E91. doi: 10.1055/s-2006-945146. Epub 2007 Apr 18.
7
Oesophagitis dissecans superficialis complicating repeated rigid oesophagoscopy and dilatation.
J Laryngol Otol. 2007 Jan;121(1):92-3. doi: 10.1017/S002221510600274X. Epub 2006 Sep 20.
8
Esophagitis dissecans superficialis associated with celiac disease.
Gastrointest Endosc. 2003 Jan;57(1):140-1. doi: 10.1067/mge.2003.42.
9
Esophagitis dissecans superficialis (esophageal cast) complicating esophageal sclerotherapy.
Am J Gastroenterol. 1998 Apr;93(4):655-6. doi: 10.1111/j.1572-0241.1998.187_b.x.
10
Esophagitis dissecans superficialis associated with pemphigus vulgaris.
J Am Acad Dermatol. 1981 Jun;4(6):682-7. doi: 10.1016/s0190-9622(81)70070-7.
Zotero 插件